OncoSec Medical Inc. to Present at the 12th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/3/2013 6:53:56 AM
OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, has announced it will be presenting at the 12th Annual BIO Investor Forum.
Punit Dhillon, President and CEO of OncoSec Medical, will provide a company overview and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
Help employers find you! Check out all the jobs and post your resume.